Results 331 to 340 of about 577,742 (361)

Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Allison J L'hotta
exaly  

Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2004
Ching-Hon, Pui, Mary V, Relling, James R, Downing   +2 more
openaire   +2 more sources

Lymphoblastic Neoplasms— T-lymphoblastic Leukemia/Lymphoma

2013
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song, Ryan T. Phan   +3 more
openaire   +3 more sources

Lymphoblastic Leukemia and Lymphoma

2009
This chapter covers T and B lymphoblastic neoplasms, including acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). Morphologic, immunophenotypic, and cytogenetic features are discussed along with the parameters of various modalities used in their diagnosis.
openaire   +2 more sources

Lymphoblastic Leukemia/Lymphoma

2018
Lymphoblastic leukemia/lymphoma (i.e., acute lymphoblastic leukemia/lymphoma or ALL) is the most common type of cancer in childhood. The age-adjusted incidence rate is 3.1/100,000 in children, so approximately 2500–3000 children are diagnosed with acute lymphoblastic leukemia (ALL) each year in the United States).
openaire   +2 more sources

Precursor B-Lymphoblastic Leukemia

ASH Image Bank, 2002
openaire   +3 more sources

Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

Leukemia, 2018
N. Toft, H. Birgens, J. Abrahamsson, L. Griškevičius, H. Hallböök, M. Heyman, T. Klausen, Ó. Jónsson, K. Palk, K. Pruunsild, P. Quist-Paulsen, G. Vaitkeviciene, K. Vettenranta, A. Åsberg, T. Frandsen, H. Marquart, H. Madsen, U. Norén-Nyström, K. Schmiegelow   +18 more
semanticscholar   +1 more source

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

Nature Medicine, 2021
Sara Ghorashian, Ajay Vora, Giovanna Lucchini   +2 more
exaly  

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine, 2023
Timothy A Yap, Naval G Daver, Jixiang Zhang   +2 more
exaly  

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly